Anticoagulation Services

• Search this site
• Terms of Use
• Contact Us
• Venous Thromboembolism (Diagnosis, Prevention Treatment)
• Optimum Therapeutic Ranges and Duration of Anticoagulation (pdf)
• Warfarin
• Dabigatran (Pradaxa)
• Rivaroxaban (Xarelto)
• Guidelines for Reversal of Anticoagulation
• Guidelines for Dosing and Monitoring of Low-Molecular Weight Heparin (LMWH)
• Peri-Procedural Anticoagulation
• Neuraxial Anesthesia in the Anticoagulated Patient
• Heparin Protocols for UWMC
• Heparin-Induced Thrombocytopenia
• Central Venous Catheter Management
• Alternative Monitoring for Antithrombotic Agents at UWMC
• Permissions Request

Frequency of Monitoring

Maintenance Therapy

• Dose held today in patient with significant over anticoagulation: In 1 - 2 days.
• Dosage change today: Within 1 - 2 weeks.
• Dosage change < 2 weeks ago: Within 2 - 4 weeks.
• Routine follow-up of medically stable & reliable patients: Every 4 - 6 weeks.
• Routine follow-up of medically unstable or unreliable patients: Every 1 - 2 weeks.